Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine.
Publication
, Journal Article
Babu, TM; Shen, X; McClelland, RS; Wang, Z; Selke, S; Wilkens, C; Hauge, KA; McClurkan, CL; Goecker, E; Laing, KJ; Koelle, DM; Greninger, AL ...
Published in: Open Forum Infect Dis
February 2024
We evaluated the immunologic response to a novel vaccine regimen that included 2 doses of NVX-CoV2373 (Novavax) followed by 1 dose of BNT162b2 (Pfizer-BioNTech) monovalent booster vaccine. A durable neutralizing antibody response to Omicron BA.4/BA.5 and BA.1 variants was observed at month 6 after the booster, while immune escape was noted for the XBB.1.5 variant.
Duke Scholars
Published In
Open Forum Infect Dis
DOI
ISSN
2328-8957
Publication Date
February 2024
Volume
11
Issue
2
Start / End Page
ofad673
Location
United States
Related Subject Headings
- 3207 Medical microbiology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Babu, T. M., Shen, X., McClelland, R. S., Wang, Z., Selke, S., Wilkens, C., … Wald, A. (2024). Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine. Open Forum Infect Dis, 11(2), ofad673. https://doi.org/10.1093/ofid/ofad673
Babu, Tara M., Xiaoying Shen, R Scott McClelland, Zijun Wang, Stacy Selke, Chloe Wilkens, Kirsten A. Hauge, et al. “Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine.” Open Forum Infect Dis 11, no. 2 (February 2024): ofad673. https://doi.org/10.1093/ofid/ofad673.
Babu TM, Shen X, McClelland RS, Wang Z, Selke S, Wilkens C, et al. Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine. Open Forum Infect Dis. 2024 Feb;11(2):ofad673.
Babu, Tara M., et al. “Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine.” Open Forum Infect Dis, vol. 11, no. 2, Feb. 2024, p. ofad673. Pubmed, doi:10.1093/ofid/ofad673.
Babu TM, Shen X, McClelland RS, Wang Z, Selke S, Wilkens C, Hauge KA, McClurkan CL, Goecker E, Laing KJ, Koelle DM, Greninger AL, Nussenzweig MC, Montefiori DC, Corey L, Wald A. Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine. Open Forum Infect Dis. 2024 Feb;11(2):ofad673.
Published In
Open Forum Infect Dis
DOI
ISSN
2328-8957
Publication Date
February 2024
Volume
11
Issue
2
Start / End Page
ofad673
Location
United States
Related Subject Headings
- 3207 Medical microbiology
- 3202 Clinical sciences